Vr Adviser, LLC Portfolio Holdings

Vr Adviser, LLC

  • $966 Million
  • Q3 2024

Vr Adviser, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $966 Million distributed in 38 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ocular Therapeutix, Inc with a value of $111M, Viridian Therapeutics, Inc.\De with a value of $88.3M, Applied Therapeutics Inc. with a value of $83.5M, Dyne Therapeutics, Inc. with a value of $78.1M, and Kal Vista Pharmaceuticals, Inc. with a value of $72.4M.

Examining the 13F form we can see an increase of $53.9M in the current position value, from $912M to 966M.

Vr Adviser, LLC is based out at New York, NY

Below you can find more details about Vr Adviser, LLC portfolio as well as his latest detailed transactions.

Portfolio value $966 Million
Healthcare: $966 Million

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$42.3M
$83.5 Million 8.65% of portfolio
9,825,000
Q3 2024 Added 2.96%

Summary

  • Portfolio
  • No. of Stocks 38
  • Current Value $966 Million
  • Prior Value $912 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 4 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track Vr Adviser, LLC Portfolio

Follow Vr Adviser, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vr Adviser, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email